BDX vs CERT · P/E 34, rev $21.84B vs rev $385.1M
Becton Dickinson and Company (BDX) versus Certara Inc (CERT) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Certara Inc (CERT) is a health information services company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CERT currently screens at market cap $1.86B.
Not investment advice. Open the BDX and CERT stock pages for the full models.
Not investment advice.